Perspective
The STS database has been a powerful, paradigmshifting, disruptive innovation in healthcare. STS ACSD-participating cardiothoracic surgeons receive customized reports with comparisons of their local performance to national benchmarks. STS ACSD has enabled cardiac surgeons and their heart team members to use highly credible clinical data in order to assess and improve the quality of care provided. Moreover, STS ACSD affords a dynamic, high quality, and comprehensive resource for clinical and health policy research. Using STS ACSD, surgeon participants actively advance the forefront of knowledge, leaving a legacy for the future generations of cardiac surgeons.
PURPOSE
Over the past 25 years, there has been increasing emphasis on using data-driven approaches to identify, monitor, report, and improve the quality of care provided within hospitals and health care delivery systems. Cardiothoracic surgery has consistently been at the forefront of this evolutionary paradigm. This News and Views article provides a brief summary of the historical development and continuing innovations of the Society of Thoracic Surgeons' (STS) Adult Cardiac Surgery Database (ACSD). We also highlight approaches used to validate the integrity of STS ACSD data, which are unparalleled in the health care industry and include documentation of completeness, accuracy, and reliability. These externally validated, highly accurate clinical data have been used for a variety of purposes, including development of sophisticated riskadjustment models and performance metrics; feedback of benchmarked results to STS ACSD participants; data-driven quality improvement activities; research; government collaborations (eg, device registries for postmarket surveillance); and databased, patient-specific informed consent and counseling.
HISTORICAL BACKGROUND
For nearly 3 decades, cardiothoracic surgery has been the national leader in clinical data registries, risk adjustment, performance measurement, and data-driven quality improvement. 1 Both the Department of Veterans Affairs (VA) and STS began their activities in these areas in 1986, on separate but parallel and similar tracks. In 1986, Congress mandated that the VA must compare risk-adjusted mortality rates for cardiac surgery with national standards (Public Law 99-166). Created in 1987, the first nationwide quality improvement national database initiative was started within the VA and was titled as "Continuous Improvement in Cardiac Surgery Program" (CICSP). 2 Rather than minimally complying with this new law's modest reporting requirements for risk-adjusted outcomes and comparative reporting, the CICSP ushered in a new quality assurance era by producing meaningful local VA cardiac surgery program-based performance reports. 3 Initiated in direct response to Health Care Financing Administration's (HCFA, the predecessor of the Centers for Medicare & Medicaid Services [CMS]) release of inadequately risk-adjusted hospital mortality reports, the STS data registry initiative also began in 1986. Following this flawed HCFA data release, STS was inundated by requests for program quality reviews. The STS issued a statement of concern in October of that year, starting an ad hoc Committee on Risk Factors for Coronary Artery Bypass Surgery. 4 In their 1988 report, STS Committee members emphasized the need to identify and adjust for all risk factors that were predictive of operative mortality to make appropriate statistical comparisons. A data working group led by Dr Richard Clark was established, and the STS database was initiated in 1989. 5 The fundamental goal of these early activities was to provide clinically relevant, timely, accurate, and reliable information to STS database participants to facilitate their local selfassessment and self-improvement activities. [6] [7] [8] By 2013, STS ACSD included 1085 participating sites, representing 90%-95% of existing US-based adult cardiac surgery programs.
DATABASE INITIATIVES
Since its inception, a key objective of the STS ACSD was to assure that the important risk factors affecting outcomes were captured. This process always involves a balance between collecting all risk factors that are even potentially clinically relevant, which is costly and time consuming, vs collection of fewer key data elements (or relying on some administrative or electronic health record [EHR] data), which reduces data collection burden but potentially excludes robust adjustment for less common but important factors. 9, 10 By the mid-1990s, STS ACSD standardized data capture forms with uniform definitions (including case-based training sample sets) were distributed, and numerous training opportunities were available for data managers and coordinators. Given the special focus placed on prospectively inputting high-quality and complete local-site data, new programs were instituted to assure data completeness and quality (described later). 11, 12 The power of STS ACSD became increasingly evident to local surgeon participants. As a return on their own local site's investment, STS providers received valuable feedback from STS ACSD, helping them understand their operative and perioperative processes and outcomes and to facilitate local quality assurance and improvement activities. 13 In 1999, the Duke Clinical Research Institute (DCRI) was awarded the STS contract for database warehousing, analysis, and reporting. The DCRI
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In a collaboration involving the STS Quality Measurement Task Force and DCRI, risk models were developed for isolated coronary artery bypass grafting (CABG) and subsequently for other procedures, including all major isolated valve and valve plus CABG operations. [14] [15] [16] In addition, interest expanded to outcomes beyond 30-day or inhospital operative mortality or major morbidity. New models were developed with a special focus placed on an expanded set of clinically relevant end points, including postoperative length of stay, longterm survival, and readmissions. [17] [18] [19] In 2007, multidimensional composite measures were first introduced. 20, 21 They addressed 2 deficiencies of traditional cardiac surgical metrics, which had focused mainly on postoperative mortality and which provided inadequate endpoints for analysis. This limited scope neglected the fact that survival alone is a necessary but insufficient quality metric, and that not all short-term survivors have had equivalent quality care. For example, a patient who experienced permanent, life-altering, dialysisdependent renal failure after surgery has had clearly a different quality result vs a survivor who experienced no complications. These innovative composite metrics have evolved to become the preferred STS method for assessing performance. They include both risk-adjusted mortality and the risk-adjusted occurrence for any of 5 major complications (stroke, renal failure, reoperation, prolonged ventilation, and sternal infection or mediastinitis). For CABG procedures, moreover, 2 additional process measures were incorporated: the use of at least 1 internal mammary artery graft and the use of all 4 National Quality Forum (NQF)Àendorsed perioperative medications. These composite metrics provide a much more comprehensive assessment of quality than riskadjusted mortality alone, and they also increase the effective sample size and reliability compared to with individual outcomes measures. [20] [21] [22] [23] From 1997-2013, the nature and scope of STS ACSD data elements continued to expand with each of 5 progressively evolving versions of the STS ACSD data capture form and definitions. New and more granular data elements were added to address particularly "high-risk" patient characteristics, such as liver disease and frailty. New registries were also initiated for postmarket surveillance of new devices, including the joint STS-ACC Transcatheter Valve Therapy (TVT) Registry for transcatheter valve treatment. Table 1 reviews the major types of variables used in STS ACSD for CABG-only models for risk-adjusted 30-day operative mortality including (1) patient demographics, (2) prior cardiac procedures, (3) status at presentation, (4) comorbidities, (5) primary cardiac disease severity, (6) general health, (7) preoperative support, and (8) selected medications.
As the knowledge base continues to expand in cardiothoracic surgery, STS ACSD has also expanded the range of risk variables it collects. This facilitates more accurate performance assessment and improvement activities, research, patient counseling, and informed decision-making. Table 1 summarizes the changes over time in data elements used in published STS ACSD risk models for CABG.
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PERFORMANCE IMPROVEMENT
It is important to remember that measurement is not a goal in itself, but rather a means to an end, which is improved outcomes and value for cardiothoracic surgery patients. The STS National Database Workforce has added a Task Force on Quality Initiatives to lead these activities. This Task Force identifies best practices in important areas of care (eg, blood conservation and ventilator management) and disseminates these to ACSD participants through a variety of modalities, including webinars and access to key literature. Numerous studies have now demonstrated marked reductions in cardiac surgery morbidity and mortality, and improved adherence to NQF-endorsed process of care practices, which many believe are directly attributable to information gleaned from the STS ACSD. [28] [29] [30] 
EXTERNAL VALIDATION
The highest recognition for a health care performance measure is endorsement by the NQF, a multistakeholder public-private partnership with an extremely rigorous vetting process. As of 2015, STS has 33 NQF-endorsed performance metrics, the largest number of any professional society in the United States. Furthermore, STS ACSD was designated as a qualified clinical data registry for the Physician Quality Reporting System (PQRS), and this has enabled STS to use many of its own performance metrics for this program.
PUBLIC REPORTING
In 2010, the STS began a landmark program for voluntary public reporting of hospital and programlevel results, and these were offered on both the Consumer Reports and the STS websites. 31, 32 As of 
Prior cardiac procedure Prior cardiac surgery
Presentation status Surgical priority/status
Percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI) accident or emergency
Pulmonary hypertension or pulmonary artery (PA) systolic pressure
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Canadian Cardiovascular Society (CCS) angina class
General health Body mass index (BMI), body surface area (BSA), height and weight, or obesity
Preoperative support Preoperative intraoperative balloon pump (IABP) or inotropic support or both
Notes "Renal Dysfunction" includes any measure of renal function (including creatinine and GFR), dialysis, or renal dysfunction or insufficiency. "Arrhythmia (any)" includes both atrial and ventricular arrhythmias.
2015, slightly less than half of all STS ACSD participants consent to public reporting. A similar program has been initiated using the STS Congenital Heart Surgery Database, and the STS General Thoracic Database plans to offer public reporting in 2016. These voluntary public reporting programs are unique in health care and demonstrate the commitment of STS to accountability and transparency.
STS ACSD DATABASE INTEGRITY
In 2006, STS initiated an audit process to evaluate the completeness and accuracy of STS ACSD. Both the ACSD and its audit process evolved over the subsequent years. To assure the accuracy of STS ACSD data, and to provide credibility and impartiality to our audit process, an external, independent agency was hired to perform yearly audits of STS ACSD records from randomly selected participants. To avoid resampling, STS ACSD participating sites were eligible for audit only every 3 years. Selected STS risk variables, especially those included in risk models, and outcome variables were audited for accuracy by comparing participant submissions to the original patient records. The number of STS ACSD sites audited increased from 24 in 2007 (3% of sites) to 86 in 2013 (8% of sites). As of 2015, the audit included 10% of STS ACSD participating sites. Across all variable categories (Table 2) , the aggregate agreement rates for more than 100,000 data elements audited each year across multiple sites ranged from 94.5% (2007) to 97.2% (2012). The Figure illustrates the variable-specific agreement trends over the past 9 years. Although the operative mortality agreement was lower in the early years, this agreement rate has remained more than 95% since 2008. Feedback from audited sites has been consistently positive, with most participants believing that the audit process improved their future STS ACSD data submission accuracy.
Over time, the external audits documented continued improvements in STS ACSD reliability. Given the random sampling process used for the audit's site selection, as well as the high degree of accuracy demonstrated, all stakeholders (eg, surgeons, health care insurers, regional quality organizations, and policy makers) using STS ACSD analyses should be extremely confident about the data, analyses, and benchmarked ratings in these reports.
RESEARCH OPPORTUNITIES
Today's medical research landscape is dynamic, and parallels the rapid advancements in biomedical 
STS ADULT CARDIAC SURGERY DATABASE
Seminars in Thoracic and Cardiovascular Surgery Volume 27, Number 2 sciences and health services research relevant to the organization, delivery, financing, and reimbursement of health care. There is increasing focus on how best to optimize patient outcomes and achieve cost-effective care-not just in the short-term, inhospital, or 30-day time frame following a cardiac surgical procedure, but also long-term survival and freedom from rehospitalizations and reinterventions. Importantly, a formal STS Research Center was established in 2011. Since then the Research Center has evaluated numerous grant proposals and has achieved federal funding for 14 grants. The STS has successfully linked their databases with other data resources, which further expands its research capabilities to address important health policy questions. 33, 34 Additionally, efforts are ongoing to transform the STS ACSD into a platform for longitudinal follow-up. This facilitates longitudinal assessment of outcomes and performance, comparative effectiveness research, device surveillance, and analysis of the economics of health care. 18, [33] [34] [35] Since its inception, numerous scientific and health policy publications have been derived from STS ACSD. Across a diversity of high-impact journals and textbooks, cardiothoracic surgery knowledge has been significantly advanced by STS ACSD, including the tracking of use and evaluation of newer treatment approaches and modalities such as off-pump CABG, 36 endoscopic vein harvest, 37 and less invasive valve surgery. 38 Beyond their intrinsic research value, these efforts have also enhanced the capability and credibility of STS ACSD by facilitating new and important collaborations with other professional associations, industry, and regulatory bodies. These include introduction of postmarket surveillance for new medical devices and therapies, as exemplified by the TVT Registry. This landmark clinical data repository for transcatheter valve replacement and repair procedures was developed as a collaborative endeavor between the STS and the American College of Cardiology, with extensive involvement from the Food and Drug Administration (FDA).
The STS and DCRI have provided a combined research infrastructure supportive of continued leadership in research, including important oversight provided by the STS Access and Publication Task Force. STS members and leadership contribute their knowledge and expertise to develop, refine, and implement studies that address important research questions. With the STS databases serving as a "gold mine" of resources, STS leadership is committed to supporting clinical research as a fundamental strategy to advance the future of cardiothoracic care. 39 
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